Cardiovascular consequences of sleep apnea: III-Impact of continuous positive airway pressure treatment Uyku apnesinin kardiyovasküler sonuçları: III- Sürekli pozitif havayolu basınç tedavisinin etkisi

The first line treatment of obstructive sleep apnea (OSA) is continuous positive airway pressure (CPAP), which has been shown to reduce daytime sleepiness and improve quality of life. However, the majority of patients with CVD and concomitant OSA do not experience daytime sleepiness, i.e. they are asymptomatic, and it has still been hardly debated whether or not all CVD patients with OSA should be treated with regard to cardiovascular aspects. In the current review, we aim to analyze available literature in this context.